Target intelligence / Profile preview

Eukaryotic translation initiation factor 4E-binding protein 2 (EIF4EBP2)

Target
EIF4EBP2
Molecular classification
Translation regulator, Other (Translation initiation factor binding protein)
01

Overview

Eukaryotic translation initiation factor 4E-binding protein 2 (EIF4EBP2) is a regulated inhibitor of translation initiation, predominantly by binding to eukaryotic translation initiation factor 4E (EIF4E) and preventing assembly of the eIF4F complex, thereby repressing cap-dependent mRNA translation. EIF4EBP2 is enriched in the brain, where it plays a key role in synaptic plasticity, neuronal stem cell maintenance, learning and memory formation. This inhibitory effect is reversed upon phosphorylation by kinases such as mTORC1, which reduces EIF4EBP2 affinity for EIF4E, allowing protein synthesis to proceed. Loss or dysregulation of EIF4EBP2 is implicated in neurological and neurodevelopmental disorders, including autism-like phenotypes in animal models, and has potential roles in cancer and response to viral infection through regulation of cell proliferation and protein production.

Other names
4E-BP2eIF4E-binding protein 24EBP2PHAS-IIPHASIIHeat and acid stable regulated by insulin protein IIEukaryotic translation initiation factor 4E binding protein 2Eukaryotic translation initiation factor 4E-binding protein 2, phosphorylated
02

Mechanism of action

Inhibition of translation initiation by binding to EIF4E and preventing its assembly into the eIF4F complex; phosphorylation by mTORC1 reduces affinity for EIF4E, permitting protein synthesis.

03

Biological functions

Negative regulation of translation initiationRegulation of protein synthesisSynaptic plasticityLearning and memory formationRegulation of neuronal stem cell renewalCell proliferationCell differentiation
04

Disease associations

Neurodevelopmental disorders (e.g., Fragile X syndrome, Angelman syndrome, autism spectrum disorder)Viral infectionPotential role in cancer (via regulation of cell proliferation)
05

Safety considerations

No prominent, established therapeutic safety concerns as a direct drug target; however, disruption of this pathway can impact protein synthesis, synaptic function, and neural development, with possible implications for neurodevelopmental toxicity.Targeting translation regulators broadly may risk affecting fundamental cellular processes in non-target tissues.
06

Interacting drugs

None documented as direct, approved therapeutics. Some mTOR inhibitors and related pathway modulators may impact EIF4EBP2 activity indirectly, but no direct clinical drugs are explicitly documented in current references.
07

Biomarkers

Not established as a validated clinical biomarker for patient selection or efficacy monitoring, but changes in phosphorylation status have mechanistic significance in research settings, especially brain/neurodevelopmental studies

Beyond the preview

Go deeper on Eukaryotic translation initiation factor 4E-binding protein 2 (EIF4EBP2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Eukaryotic translation initiation factor 4E-binding protein 2 (EIF4EBP2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call